Adalta Capital Management’s GoodRx Holdings GDRX Stock Holding History

Adalta Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,570	Closed	-$273K	–	95
2021 Q2	$273K	Hold	7,570	–	–	0.15%	66
2021 Q1	$295K	Buy	7,570 +6,250	+473%	+$281K	0.17%	57
2020 Q4	$53K	Buy	+1,320	New	+$60.6K	0.03%	78

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Adalta Capital Management's GDRX Position: Q3 2021 in Review

Adalta Capital Management sold out of GoodRx Holdings (GDRX) in Q3 2021, closing a stake of 7,570 shares — an estimated $273K sold.

Adalta Capital Management first reported a position in GDRX in Q4 2020 and held it in 3 quarters. The position peaked at $295K in Q1 2021. 218 funds tracked by Wall St. Rank hold GDRX as of Q3 2021.

Adalta Capital Management reported no remaining GoodRx Holdings position as of Q3 2021 after selling out during the quarter.
Adalta Capital Management sold 7,570 GoodRx Holdings shares in Q3 2021, an estimated $273K.
Adalta Capital Management first reported a position in GoodRx Holdings in Q4 2020 and held it in 3 quarters.
Adalta Capital Management's GoodRx Holdings position peaked at $295K in Q1 2021.
218 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2021.

Based on Adalta Capital Management's 13F filing for Q3 2021, filed 16 Nov 2021.